C4 Therapeutics (CCCC) Change in Receivables (2019 - 2025)
Historic Change in Receivables for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $4.3 million.
- C4 Therapeutics' Change in Receivables fell 5268.15% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 235337.24%. This contributed to the annual value of -$8.7 million for FY2024, which is 18421.61% down from last year.
- According to the latest figures from Q3 2025, C4 Therapeutics' Change in Receivables is $4.3 million, which was down 5268.15% from -$5.8 million recorded in Q2 2025.
- C4 Therapeutics' 5-year Change in Receivables high stood at $11.3 million for Q4 2023, and its period low was -$12.4 million during Q2 2024.
- In the last 5 years, C4 Therapeutics' Change in Receivables had a median value of -$63000.0 in 2022 and averaged $108315.8.
- As far as peak fluctuations go, C4 Therapeutics' Change in Receivables surged by 7543333.33% in 2023, and later tumbled by 258620.0% in 2024.
- Quarter analysis of 5 years shows C4 Therapeutics' Change in Receivables stood at $871000.0 in 2021, then crashed by 101.72% to -$15000.0 in 2022, then soared by 75433.33% to $11.3 million in 2023, then tumbled by 164.06% to -$7.2 million in 2024, then soared by 159.97% to $4.3 million in 2025.
- Its Change in Receivables was $4.3 million in Q3 2025, compared to -$5.8 million in Q2 2025 and $4.9 million in Q1 2025.